Huaizhang, W., Zhuotang, L. Clinical study on effect of Kang’aibao oral liquid in treating 103 patients of malignant tumor) in treating 103 patients of malignant tumor., CJIM 5, 261–264 (1999). https://doi.org/10.1007/BF02935398
Wang Huaizhang, Lin Zhuotang. Clinical study on effect of Kang’aibao oral liquid in treating 103 patients of malignant tumor) in treating 103 patients of malignant tumor. [J]. Chinese Journal of Integrative Medicine 5(4):261-264(1999)
Huaizhang, W., Zhuotang, L. Clinical study on effect of Kang’aibao oral liquid in treating 103 patients of malignant tumor) in treating 103 patients of malignant tumor., CJIM 5, 261–264 (1999). https://doi.org/10.1007/BF02935398DOI:
Wang Huaizhang, Lin Zhuotang. Clinical study on effect of Kang’aibao oral liquid in treating 103 patients of malignant tumor) in treating 103 patients of malignant tumor. [J]. Chinese Journal of Integrative Medicine 5(4):261-264(1999) DOI: 10.1007/BF02935398.
Clinical study on effect of Kang’aibao oral liquid in treating 103 patients of malignant tumor) in treating 103 patients of malignant tumor
摘要
Objective: To observe the clinical efficacy of Kang’aibao oral liquid (KABL)
a Chinese herbal preparation in treating malignant tumor of middle or advanced stage.Methods: A comparative study was done by observing the effect of 103 patients treated with KABL
and another 90 patients treated with chemotherapy at the same time were taken as the control group.Results: The immunologic function
short-term effective rate (complete relieved rate and partial relieved rate)
survival quality
1-
2- and 3-year survival rate
median survival time
and carcinoembryonic antigen (CEA) declining rate of the KABL group were significantly higher than those of the control group.Conclusion: KABL has the effects of inhibiting tumor growth
prolonging survival time and improving survival quality of tumor patients.
Abstract
Objective: To observe the clinical efficacy of Kang’aibao oral liquid (KABL)
a Chinese herbal preparation in treating malignant tumor of middle or advanced stage.Methods: A comparative study was done by observing the effect of 103 patients treated with KABL
and another 90 patients treated with chemotherapy at the same time were taken as the control group.Results: The immunologic function
short-term effective rate (complete relieved rate and partial relieved rate)
survival quality
1-
2- and 3-year survival rate
median survival time
and carcinoembryonic antigen (CEA) declining rate of the KABL group were significantly higher than those of the control group.Conclusion: KABL has the effects of inhibiting tumor growth
prolonging survival time and improving survival quality of tumor patients.
关键词
alignant tumor of middle or advanced stageKang’aibao oral liquidSurvival Timesurvival quality
Keywords
alignant tumor of middle or advanced stageKang’aibao oral liquidSurvival Timesurvival quality